Disorder of Consciousness
0
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Temple TherapeuticsNetherlands - Geleen
1 programEvaluation of the MuSICCA for Measuring AwarenessN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Temple TherapeuticsEvaluation of the MuSICCA for Measuring Awareness
Angeles TherapeuticsBX Pulsar 1002
Human BioSciencesanimal assisted therapy
NeurosteerTranscranial direct current stimulation
Clinical Trials (4)
Total enrollment: 122 patients across 4 trials
Evaluation of the MuSICCA for Measuring Awareness
Start: Apr 2022Est. completion: Dec 202780 patients
N/ARecruiting
The Use of LIFUP in Chronic Disorders of Consciousness
Start: Jun 2021Est. completion: Apr 202316 patients
N/ACompleted
Effects of Animal Assisted Therapy on Patients With Severe Disorders of Consciousness
Start: Jan 2016Est. completion: Apr 201710 patients
N/ACompleted
Excitatory Prefrontal Weak Current Stimulation in Vegetative Patients
Start: Apr 2014Est. completion: Dec 202316 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 122 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.